You are Invited to Participate in a Free Educational Webinar

Safety Assessment of Monoclonal Antibodies for Immunosuppressants and Anti-Inflammatory Agents
Wednesday, December 19, 2018

Time: 11:00 AM ET

Hosted by the American College of Toxicology

In Collaboration with the British Toxicology Society and the Society of Toxicologic Pathology

	Simone Nicholson, PhD, DABT Senior Toxicologist, Biologics Safety Assessment, MedImmune LLC Talk 1: Introduction: Biologics for the Treatment of Immune-Mediated Inflammatory Disease
	Hervé Lebrec, PharmD, PhD, DABT Scientific Director, Nonclinical Safety Sciences, Amgen Inc. Talk 2: Immune Safety Assessments for Immunosuppressive Agents: Tools and Applications
	Shawn Heidel, DVM, PhD Vice President and Head, Global Safety Assessment, Covance Laboratories, Inc. Talk 3: Carcinogenicity Assessment of Biologics
	Ken Hastings, DrPH, DABT, ATS Hastings Toxicology Consulting, LLC Talk 4: Regulatory Aspects and Interpretation of Immunosuppression AE in Nonclinical Studies

There is no fee but advance registration is required.

View Abstract

Please forward this invitation to others you feel might be interested in this webinar.

11190 Sunrise Valley Drive, Suite 300, Reston, VA 20191
Tel: 703.547.0875    Fax: 703.438.3113    Email: acthq@actox.org    Website: www.actox.org   Twitter: @ACToxicology

You may view the ACT Privacy Policy, provide consent to ACT to email you communications, or unsubscribe to stop receiving further ACT communication.
Privacy Policy   |   Provide Consent   |   Unsubscribe